Cart
sales@molnova.com
PLH1215
CAS No. 1332084-64-6
PLH1215( —— )
Catalog No. M36852 CAS No. 1332084-64-6
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 125 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 304 | In Stock |
|
| 50MG | 446 | In Stock |
|
| 100MG | 639 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1376 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePLH1215
-
NoteResearch use only, not for human use.
-
Brief DescriptionPLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
-
DescriptionPLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1332084-64-6
-
Formula Weight326.44
-
Molecular FormulaC19H26N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CCC1=CC=CC=C1)C2(CO)CN(CCC2)C3=NC(N)=NC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Suc-SDPF-pNA
Suc-SDPF-pNA
-
Lapisteride
Lapisteride (CS-891) a steroidal 5α-reductase inhibitor is used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia and may be effective in preventing or treating AGA .
-
Trifolirhizin
Trifolirhizin exerts varying degrees of inhibition on tyrosinase-dependent melanin biosynthesis, and therefore, are candidates as skin-whitening agents.
